BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Eledon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-31 5:50 pm Unchanged |
2024-10-29 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 6,293,282 10.500% |
0 (Unchanged) |
Filing |
| 2024-10-31 5:49 pm Purchase |
2024-09-30 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 6,293,282 15.900% |
1,966,572 (+45.45%) |
Filing |
| 2024-02-14 10:06 am Purchase |
2023-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 4,326,710 17.900% |
2,000,000 (+85.96%) |
Filing |
| 2022-01-28 4:35 pm Purchase |
2022-01-20 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 2,326,710 16.900% |
878,690 (+60.68%) |
Filing |
| 2022-01-10 5:57 pm Purchase |
2022-01-06 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 1,448,020 10.100% |
13,088 (+0.91%) |
Filing |
| 2022-01-10 5:51 pm Purchase |
2021-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 1,434,932 9.990% |
1,434,932 (New Position) |
Filing |